Lipospectrum has received Institutional Review Board (IRB) approval of a program to conduct large-scale studies of lipid profiles. The resultant lipid profiles can be very informative for individuals wanting to understand their health status at the molecular level. In turn, this could lead to far less invasive, extremely early warning and treatment of diseases that are often not easily managed, controlled, or treated if they are not discovered at very early stages.
Differences between Genomics and Lipidomics:
|Genomic Testing||Lipidomic Testing|
(understanding your DNA)
(understanding your lipids at the molecular level):
|While genetic testing can tell you if you have a predisposition to a disease or condition, it does not provide information about your current health status.||Your Lipid profile provides a unique snapshot of your health at the time of testing, and enables future tracking over time.|
|Genetic testing only reveals a potential risk factor – not that you will, or will not, contract the disease or condition.||Your lipid profile identifies the presence of lipid biomarkers which may lead to an early indication of the presence of lipid-based diseases – maybe before symptoms are present.|
|Genetic testing is only done once; since DNA does not change with the presence of a disease or condition.||Your lipid profile is a “real-time” indicator of your health status at the time of the test. Annual testing can be done to allow you to monitor any changes in your current health status. If biomarker changes of concern are observed, more frequent monitoring may then be advisable and provide you with the tools to monitor and take charge of your wellness.|